Harvey Chapter 7 Evaluation of Hemostasis PART II: Coag Disorders (with Schalm's) AKG Flashcards
What is the difference between the in-vitro and in-vivo model of the propagation stage of coagulation (aka activation of the intrinsic pathway)?
- In-vitro model –> factor XII comes into contact with anionic wettable surface –> autoactivation occurs to FXIIa –> FXIIa activates FXI and FXIIa interacts with prekallikrein bound to HMK
- In-vivo model –> thrombin activates FXI
FXIIa + prekallikrein –> ______ + _____
active fragment of FXIIa (FXIIf) + kallikrein
FXIIf activates ____ in addition to generating kallikrein.
complement (C1r)
Kallikrein converts ___ to ____.
HMK to bradykinin
List actions of bradykinin
- Vasodilation
- Increased vascular permeability
- Inflammation
- Stimulates release of tissue plasminogen activator (tPA) from endothelial cells –> promotes fibrinolysis
Which factor catalyzes the formation of covalent bonds between lysine and glutamine residues of different fibrin monomers that results in ‘cross linked fibrin’ that is insoluble?
FXIII
List the actions of thrombomodulin that is expressed on endothelial cells
- Anticoagulant mechanisms:
- Forms thrombin:Thrombomodulin complex that inhibits thrombin’s procoagulant activity –> inhibits coagulation
- Enhances activation of protein C on surface of endothelium –> inhibits coagulation
- Procoagulant mechanisms:
- Activates TAFI (TAFI removes carboxyterminal lysine groups from fibrin –> decreasing binding of plasminogen and tPA to fibrin –> decreased generation of plasmin –> slows down fibrinolysis
Thrombin:thrombomodulin complex enhances activation of protein C on the endothelial surface.
Activated protein C can promote fibrinolysis by inactivating ________–> may increase amount of tPA available for fibrinolysis
Activated protein C –> dissociates from endothelial receptor and interacts with protein S –> protein C:protein S degrade ___ and ___ on surface of activated platelets –> inhibits coagulation.
plasminogen activator inhibitor 1 (PAI-1)
FVa and FVIIIa (FV is in the prothrombinase complex and FVIII is in the tenase complex)
Protein S forms a complex with protein C to degrade FV and FVIII. Protein S is also a cofactor for which molecule that is synthesized by endothelial cells and is the key inhibitor of the extrinsic pathway (inhibits FXa and TF-VIIa complex)?
Tissue factor pathway inhibitor (TFPI)
List endothelial-secreted inhibitors of thrombus formation
- PGI2 and NO (powerful vasodilators)
- Ectoenzyme that degrades ADP
- Antithrombin (inhibits conversion of fibrinogen to fibrin and other proteases/coag factors F9-12) - mostly made by hepatocytes, but some from endothelial cells
- Thrombomodulin and protein C
- Tissue factor pathway inhibitor (TFPI)
Antithrombin is mostly made by which cell type?
Hepatocytes (a little is made by endothelial cells)
Antithrombin binds to ____ on the surface of endohtelial cells which accelerates inactivation of coagualation factors by antithrombin.
Heparan sulfate proteoglycans
What are the functions of antithrombin?
Main function: To inhibit conversion of fibrinogen to fibrin.
Other functions: Inhibits F9-12
Fibrinolysis is activated by release of ____ from damaged enothelium. This molecule stimulates fibrinolysis by activation ____ to ____. ____ catalyzes the hydrolysis of firbin and forms fibrin degradation products which have antihemostatic properties.
tPA (tissue plasminogen activator)
plasminogen to plasmin
Plasmin
Inhibitors of fibrinolysis:
______ is produced by endothelial cells and inhibits tPA.
______ removes carboxytermainl lysine groupes from fibrin, which decreases binding of plasminogen and tPA to fibrin –> this decreases the generation of plasmin and slows down fibrinolysis.
PAI-1 (plasminogen activator inhibitor)
TAFI (thrombin activatable fibrinolysis inhihbitor)
What is the preferred anticoagualant for coagualatoin and platelet function tests, in additaion to blood collection/stroage for transufsions?
Sodium citrate
EDTA and citrate - mechanisms of action
Heparin - mechanisms of action
EDTA and citrate are calcium chelators
Heparin binds to antithrombin –> this complex inhibits conversion of fibrinogen to fibrin and inhibits F9, 10, and FVIIa:TF complex
Hypercoagulable state = increased tendency for coagulation to occur without clinical signs or laboratory evidence of thrombosis; ‘prethrombotic state’. List factors than can predipose animals to a hypercoagulable state and that can ultimately result in thromboembbolism.
- Platelet hyperreactivity (e.g., increased IL6 and PAF during inflammation)
- Increased concentration of coag factors (e.g., hyperfibrinogenemia in response to inflammation)
- Decreased concentrations of coagulation inhibitors (e.g., decreased antithrombin secondary to nephrotic syndrome)
- Hypofibrinolysis (e.g., increased plasminogen activator inhibitor – acute-phase response to inflammation)
- Protein C deficiency in horses
- Hyperadrenocorticism in dogs
- Many dogs with neoplasia, IMHA, and parvovirus enteritis
- Many cats with hypertrophic cardiomyopathy, hyperthyroidism, liver disease
- Septic foals
- Glucocorticoid therapy
- Indwelling IV catheters
To diagnose a localized thrombus, platelet counts, coagulation tests, and FDP values may be normal. The best test that has a high sensitivity (higher than FDP) and high negative predictive value to help rule out thromboembolism and DIC is _____.
D-dimer
DIC is most often initiated by the disseminated presentation of ___ in blood.
tissue factor (TF)
Disseminated coagulation is promoted by increased #s of ____ released by stimulated platelets, monocytes, endothelial cells, tumor cells, and apoptotic cells. These ____ express procoagulant __ and ___ on their surfaces.
Microparticles
Microparticles
PS and TF
Hemorrhage is common some dogs with DIC, but uncommon in what two species?
Cats and horses
Is firbinogen always low in DIC?
No - inflammatory conditions will increase fibrinogen becuase it is a negative acute phase protein. So it may be normal to increased with DIC. If you have normal fibrinogen which it should be increased due to inflammation - should raise concern for early DIC.
TEG results for DIC patients:
Varibale
Some patients are hypercoagulable, normocoagulable, or hypocoagulable